These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 23688679)

  • 41. Anti-Neurofascin-155 IgG4 antibodies prevent paranodal complex formation in vivo.
    Manso C; Querol L; Lleixà C; Poncelet M; Mekaouche M; Vallat JM; Illa I; Devaux JJ
    J Clin Invest; 2019 Mar; 129(6):2222-2236. PubMed ID: 30869655
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neurofascin antibodies in autoimmune, genetic, and idiopathic neuropathies.
    Burnor E; Yang L; Zhou H; Patterson KR; Quinn C; Reilly MM; Rossor AM; Scherer SS; Lancaster E
    Neurology; 2018 Jan; 90(1):e31-e38. PubMed ID: 29187518
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neurofascin as a target for autoantibodies in peripheral neuropathies.
    Ng JK; Malotka J; Kawakami N; Derfuss T; Khademi M; Olsson T; Linington C; Odaka M; Tackenberg B; Prüss H; Schwab JM; Harms L; Harms H; Sommer C; Rasband MN; Eshed-Eisenbach Y; Peles E; Hohlfeld R; Yuki N; Dornmair K; Meinl E
    Neurology; 2012 Dec; 79(23):2241-8. PubMed ID: 23100406
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anti-pan-neurofascin antibodies induce subclass-related complement activation and nodo-paranodal damage.
    Appeltshauser L; Junghof H; Messinger J; Linke J; Haarmann A; Ayzenberg I; Baka P; Dorst J; Fisse AL; Grüter T; Hauschildt V; Jörk A; Leypoldt F; Mäurer M; Meinl E; Michels S; Motte J; Pitarokoili K; Stettner M; Villmann C; Weihrauch M; Welte GS; Zerr I; Heinze KG; Sommer C; Doppler K
    Brain; 2023 May; 146(5):1932-1949. PubMed ID: 36346134
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fulminant Central Plus Peripheral Nervous System Demyelination without Antibodies to Neurofascin.
    Vural A; Göçmen R; Kurne AT; Oğuz KK; Temuçin ÇM; Tan E; Karabudak R; Meinl E; Erdem Özdamar S
    Can J Neurol Sci; 2016 Jan; 43(1):149-56. PubMed ID: 26271726
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Neurofascin: a novel target for combined central and peripheral demyelination].
    Kawamura N
    Rinsho Shinkeigaku; 2014; 54(12):978-80. PubMed ID: 25672685
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neurofascin antibodies in inflammatory neuropathy: how many needles make a haystack?
    Hughes RA; Willison HJ
    Neurology; 2012 Dec; 79(23):2224-5. PubMed ID: 23100403
    [No Abstract]   [Full Text] [Related]  

  • 48. Neurofascin-140 and -155 antibodies in an atypical case of poems syndrome.
    Rempe T; Ho KWD; Shahid M; Yang LJ; Chuquilin M
    Muscle Nerve; 2019 Jul; 60(1):E1-E3. PubMed ID: 31018253
    [No Abstract]   [Full Text] [Related]  

  • 49. Homozygous mutation in the Neurofascin gene affecting the glial isoform of Neurofascin causes severe neurodevelopment disorder with hypotonia, amimia and areflexia.
    Smigiel R; Sherman DL; Rydzanicz M; Walczak A; Mikolajkow D; Krolak-Olejnik B; Kosinska J; Gasperowicz P; Biernacka A; Stawinski P; Marciniak M; Andrzejewski W; Boczar M; Krajewski P; Sasiadek MM; Brophy PJ; Ploski R
    Hum Mol Genet; 2018 Nov; 27(21):3669-3674. PubMed ID: 30124836
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel forms of neurofascin 155 in the central nervous system: alterations in paranodal disruption models and multiple sclerosis.
    Pomicter AD; Shroff SM; Fuss B; Sato-Bigbee C; Brophy PJ; Rasband MN; Bhat MA; Dupree JL
    Brain; 2010 Feb; 133(Pt 2):389-405. PubMed ID: 20129933
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Different Patterns of Autoantibody Secretion by Peripheral Blood Mononuclear Cells in Autoimmune Nodopathies.
    Rohrbacher S; Seefried S; Hartmannsberger B; Annabelle R; Appeltshauser L; Arlt FA; Brämer D; Dresel C; Dorst J; Elmas Z; Franke C; Geis C; Högen T; Krause S; Marziniak M; Mäurer M; Prüss H; Schoeberl F; Schrank B; Steen C; Teichtinger H; Thieme A; Wessely L; Zernecke A; Sommer C; Doppler K
    Neurol Neuroimmunol Neuroinflamm; 2024 Sep; 11(5):e200295. PubMed ID: 39173087
    [TBL] [Abstract][Full Text] [Related]  

  • 52. IgG4 Valency Modulates the Pathogenicity of Anti-Neurofascin-155 IgG4 in Autoimmune Nodopathy.
    Jentzer A; Attal A; Roué C; Raymond J; Lleixà C; Illa I; Querol L; Taieb G; Devaux J;
    Neurol Neuroimmunol Neuroinflamm; 2022 Sep; 9(5):. PubMed ID: 35948442
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Anti-neurofascin antibody in combined central and peripheral demyelination].
    Kawamura N
    Nihon Rinsho; 2015 Sep; 73 Suppl 7():347-51. PubMed ID: 26480724
    [No Abstract]   [Full Text] [Related]  

  • 54. Pan-Neurofascin autoimmune nodopathy - a life-threatening, but reversible neuropathy.
    Appeltshauser L; Doppler K
    Curr Opin Neurol; 2023 Oct; 36(5):394-401. PubMed ID: 37639464
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cell-based flow cytometry assay for simultaneous detection of multiple autoantibodies in a single serum sample.
    Tanimura Y; Hiroaki Y; Mori M; Fujiyoshi Y
    Anal Biochem; 2022 Aug; 650():114721. PubMed ID: 35577008
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Case report: Amnestic mild cognitive impairment in multiple domains associated with neurofascin 186 autoantibodies: Case series with follow-up and review.
    Hansen N; Sagebiel A; Rentzsch K; Hirschel S; Wiltfang J; Schott BH; Claudia B
    Front Psychiatry; 2022; 13():1054461. PubMed ID: 36713900
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antibodies against the flotillin-1/2 complex in patients with multiple sclerosis.
    Lleixà C; Caballero-Ávila M; Pascual-Goñi E; Martín-Aguilar L; Vidal N; Tejada C; Valdés-Hevia E; Zárate E; Vesperinas A; Collet R; Franco-Leyva T; Martínez-Martínez L; Moga E; Cortés-Vicente E; Rojas-García R; Gómez-Anson B; Gil A; González-Mingot C; Brieva L; Martínez-Yélamos S; Querol L
    Brain Commun; 2023; 5(2):fcad109. PubMed ID: 37091585
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg.
    Querol L; Nogales-Gadea G; Rojas-Garcia R; Diaz-Manera J; Pardo J; Ortega-Moreno A; Sedano MJ; Gallardo E; Berciano J; Blesa R; Dalmau J; Illa I
    Neurology; 2014 Mar; 82(10):879-86. PubMed ID: 24523485
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential stability of PNS and CNS nodal complexes when neuronal neurofascin is lost.
    Desmazieres A; Zonta B; Zhang A; Wu LM; Sherman DL; Brophy PJ
    J Neurosci; 2014 Apr; 34(15):5083-8. PubMed ID: 24719087
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Node of Ranvier as an Interface for Axo-Glial Interactions: Perturbation of Axo-Glial Interactions in Various Neurological Disorders.
    Dolma S; Joshi A
    J Neuroimmune Pharmacol; 2023 Jun; 18(1-2):215-234. PubMed ID: 37285016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.